ArticleProceedings of SPIE--the International Society for Optical Engineering2025
Assessment of generic corrections for multiview Cherenkov emission during total skin electron therapy (TSET).
Article in Proceedings of SPIE--the International Society for Optical Engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stereo Cherenkov imaging as 3D absolute dose monitoring tool for total skin electron therapy (TSET).Proceedings of SPIE--the International Society for Optical Engineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cherenkov imaging is a valuable tool for quality assurance of dose homogeneity in total skin electron therapy (TSET), where patients are treated in six postures using the Stanford technique. Cherenkov signals emitted from the patient's surface are captured, corrected, converted into 2D dose maps, and projected onto the body to generate a 3D pseudo dose distribution. This study aims to improve the accuracy of Cherenkov-converted doses by applying patient-specific generic correction factors derived from Monte Carlo simulations using finite element meshes (FEMs) reconstructed from 3D scans. A clinical study involving eight patients compared the corrected Cherenkov dose with in-vivo dosimetry (IVD) measurements. After applying generic corrections, the Cherenkov-converted dose showed good agreement with IVD, particularly in the shins, with discrepancies within 10%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.